Online Resources

The Michigan Anticoagulation Quality Improvement Initiative (MAQI2)
Anticoagulation Toolkit (Version 1.9) 2019

A toolkit for anticoagulation management was published by MAQI2 in 2017 and includes tools to assess stroke and bleeding risks, a comparison of the safety and efficacy of anticoagulants, patient characteristics that may influence drug selection, and a decision tree pathway for anticoagulant selection in nonvalvular atrial fibrillation (NVAF). Also included are dosing recommendations for patients transitioning between anticoagulants, a list of possible drug-drug interactions (DDIs) to consider, and patient education resources. Considerations for periprocedural management, including in patients undergoing elective cardioversion, and for bleeding management, including need for reversal, are provided. Recommendations for follow-up intervals and assessments are made.

Anticoagulation in Non-valvular Atrial Fibrillation (2018)

This 1-page schematic outlines considerations for patient assessment, anticoagulation selection, patient education topics, and long-term management for patients with NVAF that are detailed in the MAQI2 Toolkit.

Periprocedural Management (DOAC) & DOAC Interruption and Restart (2018)

This double-sided management card outlines strategies for periprocedural use of direct oral anticoagulants (DOACs) in patients with nonvalvular atrial fibrillation (NVAF) detailed in the MAQI2 Toolkit.

Atrius Health (Greater Boston Area): Anticoagulation Management Service Clinical Guideline and Practice Protocol (2017)

MaineHealth: ED Observation Protocol for Hemodynamically Stable Atrial Fibrillation

San Francisco VA Health Care System: Anticoagulation and Thrombosis Service Urgent Reversal of Oral Anticoagulants Associated Acute Intracranial (ICH) or Life Threatening Hemorrhage (2016)

University of California–Davis (UC Davis) Medical Center: Reversal of Anticoagulants at UCDMC (2017)

University of California–San Francisco (UCSF): Guidelines for the Peri-Procedural Management of Adults Taking Target Specific Anticoagulants (TSOACs): Dabigatran, Rivaroxaban, Apixaban, Edoxaban (2015)

University of Michigan Health System: Management of Acute Atrial Fibrillation and Atrial Flutter in Non-Pregnant Hospitalized Adults (2014)

University of New Mexico Hospitals
Guideline for Antithrombotic Reversal (2016)

Protocol for Periprocedural Management of Antithrombotic Therapy (2016)

Recommendations for Chronic Antithrombotic Therapy (2018)

 

University of Washington School of Medicine

Guidelines for Reversal of Anticoagulants (2018)

Management Plan Following Initiation of Direct Oral Anticoagulants (DOACs): Apixaban/Dabigatran/Edoxaban/Rivaroxaban (2015)

University of Wisconsin Health

Use of Antithrombotics in Non-Valvular Atrial Fibrillation – Adult – Inpatient/Ambulatory Clinical Practice Guideline (2016)

Management of Antithrombotic Therapy in the Setting of Periprocedural, Regional Anesthesia and/or Pain Procedures – Adult – Inpatient/Ambulatory Clinical Practice Guideline (2016) 

ED Management of Atrial Fibrillation Algorithm (2019)

Procoagulant Therapy for Bleeding Associated With Acquired Bleeding Disorders – Adult – Inpatient Clinical Practice Guideline (2015)